Future treatment priorities for high-risk MDS Published 2020-03-06 Download video MP4 360p Recommendations 03:08 The treatment protocol for higher risk MDS 02:35 What is the Best Treatment for MDS? 01:25 Prognosis and treatment in high-risk MDS 06:43 Should JAK2 VAF testing be implemented as routine in risk assessment and disease monitoring in MPN? 05:31 What are the key diagnostic criteria for confirming MGUS? 25:02 PUT SALT in this sacred corner of your house and See What Happens Next ! | BUDDHIST TEACHINGS 08:32 Peter Dauvergne (University of British Columbia, Vancouver, Canada) 31:21 Learning to Live with Post-Covid ME/CFS | Covid-19 Survivor Diaries Episode 13 04:10 Reigniting Hope to Reclaim Movement 02:18 Theo de Witte: an MDS transplant pioneer 00:54 New hope for patients with incurable and disabling Dupuytren’s disease 45:50 Treating Persistent/Chronic ITP Current Care, Future Potential 02:11 Insights into ongoing research on BTK degraders for lymphoid malignancies 01:57 Isatuximab plus pomalidomide and dexamethasone in RRMM with 1q21 gain 03:57 What is chronic lymphocytic leukaemia? 18:40 Matthew Perry's Death From Ketamine Explained (Is It Safe For You?) 04:45 Orthopaedics in Oxford 02:21 Real-world experience of the use of brexu-cel in patients with B-ALL and less than 5% marrow blasts 01:52 How do we know that bacteria were around billions of years ago? 41:06 What is Cervical Stenosis? | Jeffrey Cantor, MD Similar videos 02:43 Novel therapies in the future of MDS treatment 01:12 Future MDS treatment options 03:15 MDS: treating high and low-risk disease 06:05 The immune system's role in higher-risk MDS 02:38 How to treat difficult forms of MDS 01:47 Pevonedistat with azacitidine for high-risk MDS 25:30 When is Treatment Needed for Myelodysplastic Syndrome (MDS)? 02:18 New targets for MDS treatment 37:46 Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD 1:32:49 Community Perspectives on Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndrome 33:55 What’s on the horizon for higher-risk MDS? An update on emerging novel agents? 1:02:27 AAMDSIF 40th Anniversary Summit: Priorities for Future Research Panel Discussion 57:14 Multiple Myeloma Symposium: Future of Treatment | Dana-Farber Cancer Institute 04:26 Promising therapies on the horizon for MDS 01:32 MDS, inflammation and AML 21:48 New treatments for MPN and priority setting 00:52 Azacitidine in the treatment of MDS 00:43 MDS novel agents & HMAs More results